Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07815067 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Research Study Looking at the Effect of Timing of Meal After Dosing and Water Volume at Dosing on How the Medicine Zenagamtide is Taken up by the Body of Participants With Overweight or Obesity

Name: A Research Study Looking at the Effect of Timing of Meal After Dosing and Water Volume at Dosing on How the Medicine Zenagamtide is Taken up by the Body of Participants With Overweight or Obesity — clinical trial record (NCT07815067)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 1

SponsorNovo Nordisk A/S

Started2026-09-07

View on ClinicalTrials.gov ↗

The purpose of this clinical study is to test how taking zenagamtide tablets with different meal/water variations affects how much zenagamtide enters the bloodstream in people who have overweight or obesity. All participants will get zenagamtide.

Trial Details

NCT Number	NCT07815067
Lead Sponsor	Novo Nordisk A/S
Conditions	Overweight, Obesity
Enrollment	320 participants
Start Date	2026-09-07
Primary Completion	2028-06-12 (estimated)
Study Completion	2028-06-12 (estimated)
Updated on ClinicalTrials.gov	2026-09-11